Dimension scores are derived from public data and fields; weighted into the composite. Reference only.
Medical Asset Management, Inc. (MAMI) is a U.S.-based medical technology and services company founded in 1993. It has long served interventional radiology, interventional cardiology, electrophysiology, and related minimally invasive cardiovascular specialties. Its core offering is not a general-purpose hospital management system, but software and professional services focused on a specific part of the revenue cycle: charge capture, medical coding, reimbursement compliance, and inventory-to-billing linkage.
The main products highlighted on the official website are iRCODER and PIIMS. iRCODER is a web-based charge capture solution that emphasizes ease of use and Medicare compliance. It captures charges at the point of procedure and applies updated coding rules in real time based on procedure and service dates, reducing the manual touchpoints needed to generate a clean claim. PIIMS is a web-based inventory management tool. It is not merely for barcode tracking; it integrates with iRCODER so that devices used during procedures are deducted from inventory and billed correctly, helping reduce missed charges and the impact of back-end corrections on reimbursement.
Beyond software, MAMI also provides services focused on auditing, compliance/reimbursement assessments, outsourced coding, training courses, and publications. Its audits cover CPT, HCPCS, modifiers, and ICD-10, and the company states that they are performed according to AMA and CMS standards. Its training courses have received relevant recognition from AAPC and ASRT. For hospital departments that lack experience in interventional coding, this type of “software + expert services” combination can be valuable.
The official website does not disclose packages, pricing, a free version, or trial information; procurement requires contacting the vendor. On integration, the site states that iRCODER can work with all hospital systems and that PIIMS can integrate seamlessly with procedural charging. However, it does not specify HL7, FHIR, APIs, single sign-on, permission models, or specific third-party systems, so enterprise IT teams will still need to verify these details during evaluation.
Its strengths are deep specialty focus and strong rules-maintenance capabilities, covering charge capture, inventory billing, auditing, and training in one ecosystem. The drawbacks are limited public information, lack of transparency around security compliance, APIs, permissions, and deployment options, and an obvious design focus on the U.S. Medicare, AMA, and CMS framework. It is best suited to interventional radiology, cath labs, electrophysiology departments, and coding/revenue cycle teams in U.S. hospitals.
The official website does not provide information about access from China, and network connectivity and payment methods are unknown. Because the product depends heavily on U.S. coding and reimbursement rules, Chinese medical institutions considering deployment would need to carefully assess local medical insurance requirements, medical consumables billing, HIS/EMR integration, and compliance differences. More practical alternatives in China would be domestic vendors offering HIS, medical insurance cost-control, consumables management, and integrated billing solutions.
⚠ This review is compiled from public sources and does not constitute a purchase recommendation. Verify all facts on the vendor's official site. Verify on medicalassetmanagement.com official site.
medicalassetmanagement.com is an United States Legal & Tax provider. TG4G tracks its product information, an overall rating of 7.0/10, and a China-accessibility score of Limited (proxy recommended). Click "Visit Official Site" to reach medicalassetmanagement.com directly.